Search results
- Center for Infectious Disease Research and Policy
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Taking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19 sy...
3 days ago
- Medical Xpress
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatm...
4 days ago